---
figid: PMC4020326__jdi-5-251-g1
figlink: /pmc/articles/PMC4020326/figure/jdi12208-fig-0001/
number: F1
caption: Diverse mechanistic pathways of metformin. Metformin reduces adenosine triphosphate
  (ATP) production, increasing the cellular adenosine monophosphate (AMP)‐to‐ATP ratio,
  which leads to the activation of the liver kinase B1 (LKB1)–AMP activated protein
  kinase (AMPK) signaling pathway. Subsequently, LKB1 activates AMPK. AMPK inhibits
  mammalian target of rapamycin complex 1 (mTORC1) directly and the mTOR‐inhibitor
  through tuberous sclerosis complex (TSC)1/2 activation. Such mTORC1‐inhibition results
  in the inhibition of several carcinogenic molecules, such as ribosomal protein S6
  kinase (S6K) and hypoxia‐inducible factor‐1α (HIF‐1α). Several growth factors induce
  protein‐kinase B (PKB)/Akt activation and counteract with AMPK‐mediated TSC1/2 activation.
  Alternatively, metformin inhibits Rag‐guanosine triphosphatase (GTPase), which activates
  mTORC1.
pmcid: PMC4020326
papertitle: Cancer biology in diabetes.
reftext: Shi Sen, et al. J Diabetes Investig. 2014 May 4;5(3):251-264.
pmc_ranked_result_index: '58531'
pathway_score: 0.9446946
filename: jdi-5-251-g1.jpg
figtitle: Diverse mechanistic pathways of metformin
year: '2014'
organisms: Homo sapiens
ndex: fd49c646-deec-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4020326__jdi-5-251-g1.html
  '@type': Dataset
  description: Diverse mechanistic pathways of metformin. Metformin reduces adenosine
    triphosphate (ATP) production, increasing the cellular adenosine monophosphate
    (AMP)‐to‐ATP ratio, which leads to the activation of the liver kinase B1 (LKB1)–AMP
    activated protein kinase (AMPK) signaling pathway. Subsequently, LKB1 activates
    AMPK. AMPK inhibits mammalian target of rapamycin complex 1 (mTORC1) directly
    and the mTOR‐inhibitor through tuberous sclerosis complex (TSC)1/2 activation.
    Such mTORC1‐inhibition results in the inhibition of several carcinogenic molecules,
    such as ribosomal protein S6 kinase (S6K) and hypoxia‐inducible factor‐1α (HIF‐1α).
    Several growth factors induce protein‐kinase B (PKB)/Akt activation and counteract
    with AMPK‐mediated TSC1/2 activation. Alternatively, metformin inhibits Rag‐guanosine
    triphosphatase (GTPase), which activates mTORC1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAB1
  - STK11
  - PRKAA2
  - AKT1
  - TSC2
  - MTOR
  - PRKAG1
  - PRKAG3
  - PRKAB2
  - PRKAA1
  - PRKAG2
  - TSC1
  - MFAP1
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: LKB-1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: TSC
  symbol: TSC
  source: bioentities_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: AMP/ATPratio
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
chemicals: []
diseases: []
figid_alias: PMC4020326__F1
redirect_from: /figures/PMC4020326__F1
figtype: Figure
---
